David Hovda Net Worth

The estimated Net Worth of David Hovda is at least $189 mil dollars as of 8 December 2022. Mr. Hovda owns over 1,500 units of Pro-Dex (co) stock worth over $59,133 and over the last 12 years he sold PDEX stock worth over $130,348. In addition, he makes $0 as Independent Director at Pro-Dex (co).

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Hovda PDEX stock SEC Form 4 insiders trading

David has made over 6 trades of the Pro-Dex (co) stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 1,500 units of PDEX stock worth $3,210 on 8 December 2022.

The largest trade he's ever made was exercising 7,500 units of Pro-Dex (co) stock on 18 December 2015 worth over $16,050. On average, David trades about 2,744 units every 283 days since 2013. As of 8 December 2022 he still owns at least 2,300 units of Pro-Dex (co) stock.

You can see the complete history of Mr. Hovda stock trades at the bottom of the page.

David Hovda biography

David C. Hovda serves as Independent Director of the Company. He has served as President, Chief Executive Officer and a member of the Board of Directors of Simplify Medical, Inc., a privately held medical device company that has developed a cervical artificial disc replacement optimized for MRI imaging, since 2013. Prior to his tenure with Simplify Medical, he was President, Chief Executive Officer and a member of the Board of Directors of SpinalMotion, Inc., a privately held medical device company that designed, developed and marketed artificial discs for use in the spine, from 2004 to 2013. Prior to joining SpinalMotion, he held leadership positions with Arthrocare, Inc. (Nasdaq: ARTC), a developer and manufacturer of surgical devices, instruments, and implants focused on enhancing surgical techniques and patient outcomes, serving as the Vice President/General Manager of its Spine Division from 1999 to 2004, and as the Managing Director of its ENT Division from 1997 to 1999. From 1992 to 1997, Mr. Hovda served in financial analysis and product management positions with Medtronic, Inc. (NYSE: MDT), a multi-national medical technology company, which culminated in his service as the European Business Manager of its Upper Airway Venture from 1995 to 1997. He holds more than 40 patents related to radio frequency ablation technology, specific clinical applications, and artificial disc replacement designs and implantation methods. Mr. Hovda served for five years with the United States Navy, achieving the rank of Lieutenant. He received a Bachelor of Science degree in Civil Engineering from Northwestern University and an M.B.A. from the Harvard Graduate School of Business Administration. Mr. Hovda has been a director of ours since January 2013.

How old is David Hovda?

David Hovda is 57, he's been the Independent Director of Pro-Dex (co) since 2013. There are 2 older and 4 younger executives at Pro-Dex (co). The oldest executive at Pro-Dex Inc. (co) is Richard Lee Van Kirk Jr., 60, who is the CEO, Pres, COO & Director.

What's David Hovda's mailing address?

David's mailing address filed with the SEC is 1900 MIRAMONTE AVE., , MOUNTAIN VIEW, CA, 94040.

Insiders trading at Pro-Dex (co)

Over the last 22 years, insiders at Pro-Dex (co) have traded over $10,974,870 worth of Pro-Dex (co) stock and bought 1,372,385 units worth $2,710,370 . The most active insiders traders include Nicholas John Swenson, Ronald G Coss, eRaymond E Cabillot. On average, Pro-Dex (co) executives and independent directors trade stock every 41 days with the average trade being worth of $486,870. The most recent stock trade was executed by Angelita Rebamontan Domingo on 24 June 2024, trading 2,585 units of PDEX stock currently worth $47,306.

What does Pro-Dex (co) do?

for over 40 years pro-dex has successfully collaborated with several of the world’s largest providers of medical and dental devices. wherever you are in your process, we can help you. whether your product is partially or fully-designed, we have the capabilities to deliver the services you’re in need of. our staff is experienced in providing engineering, precision machining and fabrication, electro-mechanical assembly, components, sub-assemblies, finished products, and flexible volumes - all with exceptional service. as we’ve experienced growth at pro-dex, we’ve recognized the need to expand our engineering services division. we can offer you powerful solutions including consulting, varying engineering services, and staffing. we’re here to connect you with engineering support for the mechanical, electrical, and manufacturing needs of your company. while we may have built our business around the design and manufacturing for medical oem’s, we have since found increased success working wit

Complete history of Mr. Hovda stock trades at Pro-Dex (co)

Pro-Dex (co) executives and stock owners

Pro-Dex (co) executives and other stock owners filed with the SEC include:

• Richard Van Kirk,
  President, Chief Executive Officer, Chief Operating Officer, Director
• Richard Lee Van Kirk Jr.,
  CEO, Pres, COO & Director
• Alisha Charlton,
  Chief Financial Officer
• Alisha K. Charlton,
  CFO & Corp. Sec.
• David Hovda,
  Independent Director
• William Farrell,
  Independent Director
• Raymond Cabillot,
  Independent Director
• Katrina Philp,
  Director
• Nicholas Swenson,
  Independent Chairman of the Board
• Angel Rebamontan Domingo,
  Director and Director of Regulatory Affairs & Quality Assurance
• Nicholas John Ao Partners I...,
  
• Raymond Efarnam Street Part...,
  
• Harold A Hurwitz,
  CFO
• William L Healey,
  Director
• David Holder,
  Director
• Michael J Berthelot,
  Director
• Mark Phillip Murphy,
  Director
• George J Isaac,
  Director
• Patrick L Johnson,
  President & CEO
• Valerio F Giannini,
  Director
• Jeffrey J Ritchey,
  Chief Financial Officer
• Michael A Mesenbrink,
  Director
• Ronald G Coss,
  Director
• Angelita Rebamontan Domingo,
  Director